Results 241 to 250 of about 11,034,532 (299)

Reorganization of Innate Immune Cell Lipid Profiles by Bioinspired Meroterpenoids to Limit Inflammation

Advanced Science, EarlyView.
Resolution pharmacology is an emerging strategy to tackle inflammatory pathologies. Bioinspired meroterpenoids induce a lipid mediator class switch toward inflammation resolution in vitro and in vivo by targeting key nodes in lipid mediator biosynthesis and neutral lipid dynamics.
Lorenz Waltl, David Holubek, Klaus Speck, Raphael Wildermuth, Franz‐Lucas Haut, Stephan Permann, Immanuel Plangger, Christian Steinborn, Zhigang Rao, Danilo D'Avino, Ida Cerqua, Julia Stadler, Fiorentina Roviezzo, Peter Schlenke, Anita Siller, Harald Schennach, Solveigh C. Koeberle, Eva‐Maria Pferschy‐Wenzig, Antonietta Rossi, Thomas Magauer, Andreas Koeberle   +20 more
wiley   +1 more source

Band keratopathy and conjunctival calcification in end-stage kidney disease: epidemiology, pathophysiology and clinical management. [PDF]

Clin Kidney J
Liu N, Ren R, Gou H, Li M, Lan N, Zeng F, Yang B.   +6 more
europepmc   +1 more source

The person's experience of end stage renal disease and haemodialysis [PDF]

, 2008
Moran, Aoife
core  

Impact of a Single Hemodialysis Session on Oxidative Stress-Inducing and Oxidative Damage Biomarkers in End-Stage Kidney Disease Patients. [PDF]

Curr Issues Mol Biol
Varemmenou A, Michail E, Kalaitzopoulou E, Papadea P, Skipitari M, Papasotiriou M, Papachristou E, Goumenos D, Georgiou CD.   +8 more
europepmc   +1 more source

Feature-based clustering of hemoglobin trajectories and subsequent risk of end-stage kidney disease in stages 3-4 CKD: a landmark analysis. [PDF]

Front Nutr
Sun N, Hu N, Li J, Wang X, Zhang W, Uchida S, Han Y, Chang W.   +7 more
europepmc   +1 more source

Primary Care Involvement and Health Care Utilization Among Patients With End-Stage Kidney Disease.

JAMA Netw Open
Bailoor K, Hirth RA, Guro P, Oerline MK, Hollingsworth JM, Shahinian VB.   +5 more
europepmc   +1 more source

The Association Between Pulmonary Hypertension, End-Stage Kidney Disease, and Death: An Analysis of the Chronic Renal Insufficiency Cohort Study (CRIC). [PDF]

Kidney Med
Tuttle M, Tighiouart H, Oka T, McCallum W, Navaneethan SD, Kawut SM, Sarnak MJ.   +6 more
europepmc   +1 more source

Proenkephalin a 119-159 for evaluating glomerular filtration rate and hemodialysis adequacy in patients with end-stage kidney disease: a prospective cohort study. [PDF]

Front Med (Lausanne)
Zhang L, Gong L, Hu C, Ma J, Zhang Y, Zhang S, Hou S, Tong X, Peng Z, Liu C.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diphenhydramine Use in End-Stage Kidney Disease

American Journal of Therapeutics, 2021
Background: Diphenhydramine is commonly used in patients with kidney disease and end-stage kidney disease (ESKD) for sleep, allergic reactions, itching, and dialysis treatment related complications, and misuse associated with diphenhydramine is also reported. Diphenhydramine's pharmacokinetics property is reviewed and discussed.
Timothy, Nguyen, Beatrice, Polyakova, John, Cerenzio, Josh Renzo, Ramilo   +3 more
openaire   +2 more sources